Neurocrine Biosciences
NBIX
#1457
Rank
HK$92.56 B
Marketcap
HK$914.28
Share price
-4.42%
Change (1 day)
7.73%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): HK$5.12 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are HK$2.24 Billion. In 2023 the company made an earning of HK$2.80 Billion, an increase over its 2022 earnings that were of HK$1.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$5.12 B82.88%
2023 HK$2.80 B62.85%
2022 HK$1.72 B73.74%
2021 HK$0.99 B-8.82%
2020 HK$1.08 B77.78%
2019 HK$0.61 B49.83%
2018 HK$0.40 B-142.57%
2017 -HK$0.96 Billion-14.73%
2016 -HK$1.13 Billion53.15%
2015 -HK$0.74 Billion46.25%
2014 -HK$0.51 Billion29.66%
2013 -HK$0.39 Billion-3530.8%
2012 HK$11.27 M-95.73%
2011 HK$0.26 B
2009 -HK$0.38 Billion-45.38%
2008 -HK$0.68 Billion-58.87%
2007 -HK$1.66 Billion87.3%
2006 -HK$0.89 Billion351.97%
2005 -HK$0.2 Billion-52.09%
2004 -HK$0.41 Billion-10.98%
2003 -HK$0.46 Billion
2001 -HK$0.35 Billion
1999 -HK$0.16 Billion108.32%
1998 -HK$73.96 Million
1996 HK$22.57 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$0.16 B-96.73%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$9.46 B 85.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$0.24 Billion-104.63%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$79.02 B 1,445.68%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$55.00 B 975.99%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.44 Billion-284.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.27 B-94.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.33 Billion-106.36%๐Ÿ‡บ๐Ÿ‡ธ USA